← FDA DRUG APPROVALS

FDA ANDA · ANDA074880

ALBUTEROL SULFATE

Sponsor: NEPHRON

APPLICATION
ANDA074880
TYPE
ANDA
ORIGINAL APPROVAL
1997-09-17
LATEST ACTION
2007-03-28
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 0.083% BASE · SOLUTION · INHALATION

Approval history

2007-03-28Labeling · Supplement 12AP
2001-06-06Manufacturing (CMC) · Supplement 11AP
2001-06-06Manufacturing (CMC) · Supplement 10AP
2000-08-17Labeling · Supplement 7AP
2000-08-17Manufacturing (CMC) · Supplement 8AP
1999-10-29Manufacturing (CMC) · Supplement 5AP
1999-07-21Manufacturing (CMC) · Supplement 3AP
1998-10-26Labeling · Supplement 2AP
1997-11-20Labeling · Supplement 1AP
1997-09-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →